Clinical trial
Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And…
NCT00460148 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00460148 |
|---|---|
| Title | Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole |
| Official title | An Open Label, Repeat Dose, Dose Escalation Study Conducted in Parkinson's Disease Patients to Characterize the Pharmacokinetics and Effect of Food on Ropinirole Prolonged Release (PR/CR) 12mg Tablets. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | Ropinirole |
| Enrollment | 28 |
| Start date | Apr 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Apr 13, 2007 |
| Last update posted | Oct 28, 2016 |
| Countries | Germany, South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: